Crisaderm - 10gm

Oinment

Pack Size : 1 Tube x 1 Packet

Generics : Crisaborole

Manufacturer : Incepta Pharmaceuticals Ltd.

Best Price * TK 500.00

* Delivery will be done in Dhaka city only.

Alternative Product

More Information About - Crisaderm - 10gm

Description

Generic Name

Crisaborole topical

Precaution

Hypersensitivity reactions reported, including contact urticaria; signs and symptoms may include severe pruritus, swelling, and erythema at the application site or at a distant site; discontinue immediately and initiate appropriate therapy if hypersensitivity suspected

Indication

Indicated for mild-to-moderate atopic dermatitis

Contra Indication

History of hypersensitivity to crisaborole or any component of the formulation

Dose

Topical Atopic Dermatitis Indicated for mild-to-moderate atopic dermatitis Apply a thin layer topically to affected area(s) BID

Side Effect

1-10% Application site pain, burning, or stinging (4%) <1% Contact urticaria

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

Phosphodiesterase (PDE)-4 inhibitor; results in increased intracellular cyclic adenosine monophosphate (cAMP) levels The specific mechanism by which crisaborole exerts its therapeutic action for atopic dermatitis is not well defined, although cAMP is thought to decrease the proinflammatory response (eg, cytokine release) associated with atopic dermatitis

Interaction

N/A

Pregnancy Category Note

Pregnancy There are no available data in pregnant women to inform the drug-associated risk for major birth defects and miscarriage Crisaborole is systemically absorbed Lactation Unknown if distributed in human breast milk Crisaborole is systemically absorbed Consider the developmental and health benefits of breastfeeding along with the mother?s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition

Adult Dose

Topical Atopic Dermatitis Indicated for mild-to-moderate atopic dermatitis Apply a thin layer topically to affected area(s) BID

Child Dose

Atopic Dermatitis Indicated for mild to moderate atopic dermatitis in infants and children aged ?3 months <3 months: Safety and efficacy not established >3 months: Apply a thin layer topically to affected area(s) BID

Renal Dose

N/A

Administration

Topical Administration Apply thin layer of ointment to affected areas BID Wash hands after applying ointment, unless hands are being treated For topical use only; not for ophthalmic, oral, or intravaginal use

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.